Cargando…
S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428426/ http://dx.doi.org/10.1097/01.HS9.0000967688.12579.64 |
| _version_ | 1785090466347220992 |
|---|---|
| author | Offner, Fritz Decaux, Olivier Hulin, Cyrille Anguille, Sébastien Sophie Michallet, Anne Costa, Luciano Touzeau, Cyrille Boyd, Kevin Vishwamitra, Deeksha Guo, Yue Niu, Zhuolu Larsen, Julie Chen, Lingling Banerjee, Arnob Goldberg, Jenna Matous, Jeffrey |
| author_facet | Offner, Fritz Decaux, Olivier Hulin, Cyrille Anguille, Sébastien Sophie Michallet, Anne Costa, Luciano Touzeau, Cyrille Boyd, Kevin Vishwamitra, Deeksha Guo, Yue Niu, Zhuolu Larsen, Julie Chen, Lingling Banerjee, Arnob Goldberg, Jenna Matous, Jeffrey |
| author_sort | Offner, Fritz |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428426 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104284262023-08-17 S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY Offner, Fritz Decaux, Olivier Hulin, Cyrille Anguille, Sébastien Sophie Michallet, Anne Costa, Luciano Touzeau, Cyrille Boyd, Kevin Vishwamitra, Deeksha Guo, Yue Niu, Zhuolu Larsen, Julie Chen, Lingling Banerjee, Arnob Goldberg, Jenna Matous, Jeffrey Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428426/ http://dx.doi.org/10.1097/01.HS9.0000967688.12579.64 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Offner, Fritz Decaux, Olivier Hulin, Cyrille Anguille, Sébastien Sophie Michallet, Anne Costa, Luciano Touzeau, Cyrille Boyd, Kevin Vishwamitra, Deeksha Guo, Yue Niu, Zhuolu Larsen, Julie Chen, Lingling Banerjee, Arnob Goldberg, Jenna Matous, Jeffrey S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY |
| title | S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY |
| title_full | S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY |
| title_fullStr | S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY |
| title_full_unstemmed | S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY |
| title_short | S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY |
| title_sort | s194: teclistamab (tec) + nirogacestat (niro) in relapsed/refractory multiple myeloma (rrmm): the phase 1b majestec-2 study |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428426/ http://dx.doi.org/10.1097/01.HS9.0000967688.12579.64 |
| work_keys_str_mv | AT offnerfritz s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT decauxolivier s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT hulincyrille s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT anguillesebastien s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT sophiemichalletanne s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT costaluciano s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT touzeaucyrille s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT boydkevin s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT vishwamitradeeksha s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT guoyue s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT niuzhuolu s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT larsenjulie s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT chenlingling s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT banerjeearnob s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT goldbergjenna s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT matousjeffrey s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study |